SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000950170-23-051662
Filing Date
2023-10-03
Accepted
2023-10-03 17:15:53
Documents
2
Period of Report
2023-09-29

Document Format Files

Seq Description Document Type Size
1 3 ownership.html 3  
1 3 ownership.xml 3 8470
2 EX-24 krtx-ex24.htm EX-24 7625
  Complete submission text file 0000950170-23-051662.txt   17437
Mailing Address 99 HIGH STREET 26TH FLOOR BOSTON MA 02110
Business Address 99 HIGH STREET 26TH FLOOR BOSTON MA 02110 857-449-2244
Karuna Therapeutics, Inc. (Issuer) CIK: 0001771917 (see all company filings)

IRS No.: 270605902 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address KARUNA THERAPEUTICS, INC. 99 HIGH STREET, 26TH FLOOR BOSTON MA 02110
Business Address
Brown Jason Parker (Reporting) CIK: 0001993170 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-38958 | Film No.: 231305337